Doubt it will be a formal ban, just none available. Between a large population and ‘soft power’ objectives, I expect the Russian vaccine is already fully spoken for months.
1 Like
Would that depend on how much PPT is added to the bill (Personal Putin Tax)?
Just going back to the comment I made this morning, about the interval between doses of up to 11-12 weeks providing stronger protection/resistance I have found the below.
Interesting that the initial views of the government medical advisors, that an increased interval showed signs of providing increased effectiveness…here
Look like they’re now being supported
https://www.ft.com/content/ca3c466d-7a37-4485-b878-eb3f6c02bc8b
2 Likes
Well…
3 Likes
It might have something to do with the bollocks we’ve made over the trade deal and suffering the highest death rate in the world of any country bigger than Belgium. Sort of takes the gloss off it.
1 Like
The odd newspaper (term used loosely including one that shall not be named here) has had a go however.
1 Like
One thing I find really odd is France, Germany, Italy, Poland, Austria, Sweden (guesstimate 60% of EU population) are not recommending the AZ vaccine for over 65s.
The reason cited is not enough evidence.
When you consider 2 months ago the UK started mass vaccinations on those typically over 65 you effectively have one of the largest data sets. Even taking Lancet paper above you have a reasonable amount of those who are older (>1000)
2 Likes
I wondered this as well but then asked is there any back up testing taking place after vaccination? I haven’t heard of any but I could be very wrong on that. Nothing new there.
1 Like
Isn’t the UK data for Pfizer and Moderna if any? those are the vaccines being used on the majority of older citizens in the UK.
2 Likes
i read on the interwebs that your captain Tom died overnight.
i know he had a great innings, and hes a name amongst too many others, but given everything he did, and a bit of symbolism, what a terrible moment.
RIP and condolences to the family and you as a nation. lost a great human being.
1 Like
No, Moderna not yet being used. Don’t know the breakdown between Pfizer and AZ but plenty of older people definitely getting AZ.
There really is no evidence in yet though, at least not from the UK. AFAIK the EU will be following the recommended 28 interval between jabs. The UK’s first AZ shot took place on 4th Jan. If the UK is doing 12 week intervals for everyone (I’m not 100% site if this is the case) there isn’t a single person who has had the second AZ jab yet.
1 Like
AZ shots have been administered for less than a month.
2 Likes
That’s what I thought but posted before verifying because ISMF’s post seemed to suggest otherwise.
Whatever I’m happy with how things are going I doubt many AZ vaccines will make it into France for a while anyway.
Is there any evidence showing how it performs against the Kent, SA and Brazilian variants?
The data is from trials in Brazil, UK and South Africa that began last year. Ergo there is plenty of data for those who have had their second dose 12 weeks after their first. Maybe read the paper from the lancet, link above.
[For GoneKloppo and Flobs]
Doubt it, the data is likely Russian. I have no idea how much sequencing the Russians have been doing. Will check.
edit: the data is from a trial in the field, gathered from usage in Russia. Nothing reported on sequencing, so no data to support - from what we know of the variants’ distribution, unlikely to have been many cases in Russia in the Fall. Theoretically, apparently it should be in line with the AZ performance.
2 Likes
It’s unclear what you are referring to. ISMF suggested there was surely enough data from the UK AZ vaccination programme, which started 29 days ago, about the efficacy of over 65s. From what I can tell, those that were jabbed at the start of January have only just gone over the threshold of the 22 days that Oxford-AZ recommends as the start of efficacy. So right now, there is nothing to take from the UK AZ vaccine programme in terms of the 65+.
There’s already data showing effectiveness after the first dose in over 65s both from the trials and from its roll out. There is also trial data showing the effectiveness of extending the interval to up to 12 weeks. In fact, the data shows that the vaccine is MORE effective if the interval is extended to a 10-12 week sweetspot.
1 Like
Hold up my hands didn’t realize widespread use was not until the 4th of January.
However but to an extent the point still stands. The two aspects are is it safe, and does it work ?
For the question is it safe, I don’t believe any concerns have been raised about the AZ vaccine ? Given it has now been given to a few million people. Effects you would anticipate typically would occur within 72 hours.
The second aspect is does it work ? The the papers seem to make no distinction between age of efficiency. Testing large numbers (1000+ over 70s). Whist it does not break down the data. However if there was a significant difference in age groupings you would have anticipated that this would be reported.
1 Like